Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Jan 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

31 Jan 2016 ValuEngine, Inc. 11 $25.00

CERULEAN PHARMA INC (CERU=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Jan 2016 Pechala's Reports 2 $25.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharmaceutic...

22 Jan 2016 GlobalData 54 $300.00

Wright Investors Service Comprehensive Report for Cerulean Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Jan 2016 Wright Reports 50 $75.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharmaceutic...

02 Dec 2015 GlobalData 60 $300.00

CERULEAN PHARMA - COLLABORATING WITH BIG PHARMA

Cerulean reported in-line Q3 results on 16 November followed by an investor call highlighting its growing clinical program fo...

19 Nov 2015 Edison Investment Research 3 $10.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, Nov. 16, 2015 / 4:30PM ET

Edited Event Transcript of CERU.OQ conference call, Nov. 16, 2015 / 4:30PM ET Boston, Nov 17, 2015 (Thomson StreetEvent...

16 Nov 2015 Thomson Reuters StreetEvents 18 $75.00

CERULEAN PHARMA - MULTIPLE PRICE INFLECTIONS ON CLINICAL PIPELINE

Cerulean is on track to announce critical Phase II trial results for CRLX101 in metastatic renal cancer (mRCC) in H116 follow...

10 Sep 2015 Edison Investment Research 12 $10.00